EverImmune (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth servicesManufacturing
Business model:B2B
EverImmune is a biotech company developing treatments based on Oncobax AM, Akkermansia muciniphila, as a key bacterial commensal driving the clinical efficacy of anticancer therapeutics in cancer patients.
values in USD
Investments 5.71M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to EverImmune
Name | Criteria | |
---|---|---|
![]() |
Cebiotex
55%
|
|
![]() |
Cell-Easy
55%
|
|
![]() |
GeneMe
55%
|
|
![]() |
Rheon Medical
55%
|
|
![]() |
Bactolife
55%
|
|
![]() |
Intrance Medical Systems
55%
|
|
![]() |
Herbolea
55%
|
|
![]() |
Bainan Biotech
50%
|
|
![]() |
Biograil
50%
|
|
![]() |
Biomes
50%
|
|